Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- University of Washington
- Study ID
- NCT01050504
- Status
- Recruiting
Conditions
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- Malignant Solid Neoplasm
- Metastatic Malignant Neoplasm in the Bone
- Metastatic Malignant Neoplasm in the Soft Tissues
- Metastatic Renal Pelvis and Ureter Urothelial Carcinoma
- Recurrent Bladder Carcinoma
- Recurrent Prostate Carcinoma
- Recurrent Renal Pelvis and Ureter Urothelial Carcinoma
- Stage IV Bladder Cancer AJCC v7
- Stage IV Bladder Urothelial Carcinoma AJCC v7
- Stage IV Prostate Cancer AJCC v7
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Cytology Specimen Collection Procedure — OTHERCorrelative studies
- Laboratory Biomarker Analysis — OTHERCorrelative studies
Study Details
This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients with prostate or bladder/urothelial cancer in the laboratory may help doctors learn more about new biomarkers, potential drug targets, and resistance developing in response to treatment. It may also help doctors find better ways to treat the cancer.
Key Dates
- Start date
- Aug 31, 2009
- Status verified
- Jan 2026
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: Ancillary-correlative (blood and tissue collection)Patients undergo collection of blood and tissue samples for analysis via mutation mapping, DNA sequencing, gene expression microarray, and gene profiling.
Primary Outcome Measure
DNA genomic sequencing [ Time Frame: Up to 6 years ]
Central Contacts
- Robert B. Montgomery206-598-0856
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Robert B. Montgomery (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate CancerRecruiting · University of Washington · Baltimore, Maryland
- Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningRecruiting · Fred Hutchinson Cancer Center · Manhasset, New York